Search research articles
Contact Us
Filters
Showing results (161-170 of 197) with videos related to
Page
of 20
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 8, 2017
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study
Elisabeth M G de Vries, Martti Färkkilä, Piotr Milkiewicz, et al.
Hepatology Communications
|
August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- mice
Cristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.
The American Journal of Gastroenterology
|
August 14, 2024
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls
Kris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Hepatology (Baltimore, Md.)
|
September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
Britt A Blokker, Monica Maijo, Marta Echeandia, et al.
Hepatology (Baltimore, Md.)
|
November 10, 2018
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis
Eva Santamaría, Carlos M Rodríguez-Ortigosa, Iker Uriarte, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 3, 2025
Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study
Maria Arechederra, Emil Bik, Carla Rojo, et al.
JHEP Reports : Innovation in Hepatology
|
December 13, 2023
Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis
Jeremy S Nayagam, Tobias J Weismüller, Piotr Milkiewicz, et al.
Journal of Hepatology
|
June 24, 2022
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Ibone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, et al.
Hepatology Communications
|
February 15, 2024
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis
Rebekka J S Salzmann, Christina Krötz, Tudor Mocan, et al.
Journal of Autoimmunity
|
October 12, 2010
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis
Haiying Liu, Gary L Norman, Zakera Shums, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 197) with videos related to
Sort By:
Page
of 20
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 8, 2017
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study
Elisabeth M G de Vries, Martti Färkkilä, Piotr Milkiewicz, et al.
Hepatology Communications
|
August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- mice
Cristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.
The American Journal of Gastroenterology
|
August 14, 2024
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls
Kris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Hepatology (Baltimore, Md.)
|
September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
Britt A Blokker, Monica Maijo, Marta Echeandia, et al.
Hepatology (Baltimore, Md.)
|
November 10, 2018
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis
Eva Santamaría, Carlos M Rodríguez-Ortigosa, Iker Uriarte, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 3, 2025
Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study
Maria Arechederra, Emil Bik, Carla Rojo, et al.
JHEP Reports : Innovation in Hepatology
|
December 13, 2023
Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis
Jeremy S Nayagam, Tobias J Weismüller, Piotr Milkiewicz, et al.
Journal of Hepatology
|
June 24, 2022
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Ibone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, et al.
Hepatology Communications
|
February 15, 2024
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis
Rebekka J S Salzmann, Christina Krötz, Tudor Mocan, et al.
Journal of Autoimmunity
|
October 12, 2010
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis
Haiying Liu, Gary L Norman, Zakera Shums, et al.
Page
of 20